NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
08/08/2023
Back to search
Official data from USPTO
COMPLEGENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COMPLEGENT
ST13
US500000090803650Class
40, 42
Filing
90803650
Registration
6915728
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
08/08/2023
Trademark type
Word
Nice classes
40, 42
Filing date
06/30/2021
Registration date
12/06/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/06/2022
Last transaction
04/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
MESSICK, TABITHA
Law office
L40
Current location
TMEG LAW OFFICE 104
Holders and representatives
Holders
Kyowa Kirin Co., Ltd.
Representatives
Bassam N. Ibrahim BUCHANAN INGERSOLL & ROONEY PC
Technical classification
Nice Classes
Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Contract manufacturing service in the field of antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of host cells; custom manufacturingcontract refiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals; providing information in the field of custom manufacturing in the field of antibodiesfragments of antibodiesderivatives of antibodies; technical consultation in the field of custom manufacturing in the field of antibodiesfragments of antibodiesderivatives of antibodies; providing information in the field of custom manufacturing in the field of cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; technical consultation in the field of custom manufacturing in the field of cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; providing information in the field of custom manufacturing in the field of transfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; technical consultation in the field of custom manufacturing in the field of transfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; providing information in the field of custom manufacturing in the field of host cells; technical consultation in the field of custom manufacturing in the field of host cells; providing technical information in the field of contract manufacturing that consists of extractingrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals; technical consultation in the field of manufacturing that consists of extractingrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals
Class 42
Development of new products for others in the field of antibodiesfragments of antibodiesderivatives of antibodiescells that manufacture antibodiesfragments of antibodiesderivatives of antibodiestransfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodieshost cells; Providing technical information in the field of development of new products in the field of antibodiesfragments of antibodiesderivatives of antibodiescells that manufacture antibodiesfragments of antibodiesderivatives of antibodiestransfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodieshost cells; Technical consultation in the field of development of new products in the field of antibodiesfragments of antibodiesderivatives of antibodiescells that manufacture antibodiesfragments of antibodiesderivatives of antibodiestransfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodieshost cells
Publications
History of USPTO decisions and trademark events.
26 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/06/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/03/2023
ES7R
TEAS SECTION 7 REQUEST RECEIVED
12/21/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/06/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
11/14/2022
APET
ASSIGNED TO PETITION STAFF
10/20/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
10/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/20/2022
PUBO
PUBLISHED FOR OPPOSITION
09/20/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/31/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/13/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
07/27/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/27/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/25/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/16/2022
GNRT
NON-FINAL ACTION E-MAILED
02/16/2022
CNRT
NON-FINAL ACTION WRITTEN
02/16/2022
DOCK
ASSIGNED TO EXAMINER
02/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2021
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
07/21/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/21/2021
NWAP
NEW APPLICATION ENTERED
07/03/2021
Continuous trademark protection
Get notified about every new filing that threatens COMPLEGENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.